洞察到单和双胺胺的脂质体封装
Abdullahi Magaji Dauda1, Thomas Swift2, Richard Telford2
1Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford Bradford UK g.ruizestrada@bradford.ac.uk.
RSC pharmaceutics
|June 20, 2024
概括
含有米托纳菲德类似物的脂质体显示出更好的封装效率和更快的药物释放,具有灵活的脂质双层. 这些发现对于开发有效的脂肪体药物递送系统用于癌症治疗至关重要.
科学领域:
- 制药科学 制药科学
- 药物运输 药物运输 药物运输
- 纳米技术纳米技术
背景情况:
- 潜在的抗癌药物米托纳菲德具有神经毒性,限制了其临床使用.
- 脂质体配方提供了一种改善药物输送和降低毒性的策略.
研究的目的:
- 为了研究脂质体配方参数对米托纳菲德及其二极体模拟物的影响.
- 评估这些脂质体的物理化学特性和体外治疗疗效.
主要方法:
- 准备了具有不同双层刚度和加载方法 (双层与核心) 的脂质体.
- 评估了封装效率 (EE%),物理化学特性 (DOSY NMR,光谱法),以及体外药物释放.
- 用MDA-MB-231和RT-112癌细胞系来评估细胞疗效.
主要成果:
- 米托纳菲德二元模拟物在刚性和灵活的双层中显示了可比的EE%,与单体不同.
- 度梯度核心加载增强的单体封装.
- 灵活的双层促进了更快的药物释放,与光谱学发现相关.
- 脂质双层特性和加载方法影响了封装,特性,光活性和稳定性.
结论:
- 脂质体配方设计,包括双层特性和加载策略,显著影响米托纳菲德的输送.
- 灵活的脂质体增强药物释放,为改善治疗结果提供了潜力.
- 这项研究提供了关于优化脂质体米托纳菲德配方以提高疗效和降低毒性方面的见解.
更多相关视频
相关概念视频
What are Membranes?
A key characteristic of life is the ability to separate the external environment from the internal space. To do this, cells have evolved semi-permeable membranes that regulate the passage of biological molecules. Additionally, the cell membrane defines a cell’s shape and interactions with the external environment. Eukaryotic cell membranes also serve to compartmentalize the internal space into organelles, including the endomembrane structures of the nucleus, endoplasmic reticulum and Golgi...
Lipids as Anchors
In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
COP Coated Vesicles
Membrane-enclosed structures called vesicles transport proteins and lipids across the cell. The vesicles derive their cargo from the plasma membrane, Golgi, ER, or endosome. Coated vesicles are spherical, protein-coated carriers with a 50–100 nm diameter that mediate bidirectional transport between the ER and the Golgi. The distribution of proteins between the ER and Golgi complex is dynamic and is maintained by different coated vesicles. Their formation is driven by the assembly of different...
Oligosaccharide Assembly
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
Protein Folding Quality Check in the RER
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
The Proteasome Structure
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...


